Abstract
Although the discovery of mutations on BRCA1 and BRCA2 genes associated with high breast cancer risk has given rise to screening and surveillance initiatives, there is little documentation on why high-risk women choose to enter screening programs. The objective of this qualitative study was to develop a detailed understanding of the experiences and decisions that motivate women with increased risk of hereditary breast cancer to participate in the multicentered Quebec experimental breast screening program. Our study involved 21 participants who were either BRCA carriers or at risk and untested. These women were interviewed while participating in the screening program. Our study demonstrates that intensive screening programs may provide valuable reassurance for women with increased familial risk of hereditary breast cancer, who count on early detection and rapid response from professionals if and when a problem arises. Health professionals must take these and others concerns into account to ensure their interventions are most consistent with women’s needs.
Similar content being viewed by others
References
Ayres, L., Kavanaugh, K., & Knafl, K. A. (2003). Within-case and across-case approaches to qualitative data analysis. Qualitative Health Research, 13(6), 871–883. doi:10.1177/1049732303013006008.
Berry, D. A., Iversen, E. S., Gudbjartsson, D. F., Hiller, E. H., Garber, J. E., Peshkin, B. N., et al. (2002). BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. Journal of Clinical Oncology, 20(11), 2701–2712. doi:10.1200/JCO.2002.05.121.
Biesecker, B. B., Ishibe, N., Hadley, D. W., Giambarresi, T. R., Kase, R. G., Lerman, C., et al. (2000). Psychosocial factors predicting BRCA1/BRCA2 testing decisions in members of hereditary breast and ovarian cancer families. American Journal of Medical Genetics, 93(4), 257–263. doi:10.1002/1096-8628(20000814)93:4<257:AID-AJMG1>3.0.CO;2-8.
Bonadona, V., Saltel, P., Desseigne, F., Mignotte, H., Saurin, J. -C., Wang, Q., et al. (2002). Cancer patients who experienced diagnostic genetic testing for cancer susceptibility: Reactions and behavior after the disclosure of a positive test result. Cancer Epidemiology, Biomarkers & Prevention, 11, 97–104.
Cappelli, M., Surh, L., Humphreys, L., Verma, S., Logan, D., Hunter, A., et al. (1999). Psychological and social determinants of women’s decisions to undergo genetic counseling and testing for breast cancer. Clinical Genetics, 55, 419–430. doi:10.1034/j.1399-0004.1999.550605.x.
Denzin, N. K., & Lincoln, Y. S. (1994). Handbook of Qualitative Research. Thousand Oaks, CA: Sage Publications.
Deslauriers, J. -P. (1991). Recherche qualitative : Guide pratique. Montréal: Chenelière Education /McGraw Hill.
Eaden, J., Mayberry, M. K., Sherr, A., & Mayberry, J. F. (2001). Screening: the legal view. Public Health, 115(3), 218–221.
Geller, G., Doksum, T., Bernhardt, B. A., & Metz, S. A. (1999). Participation in breast cancer susceptibility testing protocols: influence of recruitment source, altruism, and family involvement on women’s decisions. Cancer Epidemiology, Biomarkers & Prevention, 8, 377–383.
Giordano, L., Rowinski, M., Gaudenzi, G., & Segnan, N. (2005). What information do breast cancer screening programmes provide to Italian women? European Journal of Public Health, 15(1), 66–69. doi:10.1093/eurpub/cki117.
Gurmankin, A. D., Domchek, S., Stopfer, J., Fels, C., & Armstrong, K. (2005). Patients’ resistance to risk information in genetic counseling for BRCA1/2. Archives of Internal Medicine, 165, 523–529. doi:10.1001/archinte.165.5.523.
Hallowell, N. (2000). A qualitative study of the information needs of high-risk women undergoing prophylactic oophorectomy. Psycho-Oncology, 9, 586–495. doi:10.1002/1099-1611(200011/12)9:6<486::AID-PON478>3.0.CO;2-Y.
Isaacs, C., Peshkin, B. N., Schwartz, M., DeMarco, T. A., Main, D., & Lerman, C. (2002). Breast and ovarian cancer screening practices in healthy women with a strong family history of breast or ovarian cancer. Breast Cancer Research and Treatment, 71(2), 103–112. doi:10.1023/A:1013800409238.
Kenen, R., Ardern-Jones, A., & Eeles, R. (2003). Living with chronic risk: healthy women with a family history of breast/ovarian cancer. Health Risk & Society, 5(3), 315–331. doi:10.1080/13698570310001607003.
Kirsch, S. A. E., & Brandt, P. A. (2002). Telephone interviewing: a method to reach fathers in family research. Journal of Family Nursing, 8(1), 73–84. doi:10.1177/107484070200800105.
Kvale, S. (1995). The social construction of validity. Qualitative Quarterly, 1, 19–40.
Lerman, C., Hughes, C., Croyle, R. T., Main, D., Durham, C., Snyder, C., et al. (2000). Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing. Preventive Medicine, 31(1), 75–80. doi:10.1006/pmed.2000.0684.
Lim, J., Macluran, M., Price, M., Bennett, B., Butow, P., et al. (2004). Short-and long-term impact of receiving genetic mutation results in women at increased risk for hereditary breast cancer. Journal of Genetic Counseling, 13(2), 115–133. doi:10.1023/B:JOGC.0000018822.56297.a6.
Lodder, L., Frets, P. G., Trijsburg, R. W., Klijn, J. G. M., Seynaeve, C., Tilanus, M. M. A., et al. (2003). Attitudes and distress levels in women at risk to carry a BRCA1/BRCA2 gene mutation who decline genetic testing. American Journal of Medical Genetics, 119A(3), 266–272. doi:10.1002/ajmg.a.10168.
Lodder, L. N., Frets, P. G., Trijsburg, R. W., Meijers-Heijboer, E. J., Klijn, J. G. M., Duivenvoorden, H. J., et al. (1999). Presymptomatic testing for BRCA1 and BRCA 2: how distressing are the pre-test weeks? Journal of Medical Genetics, 36, 906–913.
Metcalfe, K. A., Liede, A., Hoodfar, E., Scott, A., Foulkes, W. D., & Narod, S. A. (2000). An evaluation of needs of female BRCA1 and BRCA2 carriers undergoing genetic counselling. Journal of Medical Genetics, 37, 866–874. doi:10.1136/jmg.37.11.866.
Metcalfe, K. A., Ghadirian, P., Rosen, B., Foulkes, W., Kin-Sing, C., Eisen, A., et al. (2007). Variation in rates of uptake of preventive options by Canadian women carrying the BRCA1 or BRCA2 genetic mutation. Open Medicine, 1(2), E92–E98.
Nelson, H. D., Huffman, L. H., Fu, R., & Harris, E. L. (2005). Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. preventive services task force. Annals of Internal Medicine, 143(5), 362–379.
Payne, S. (1990). Lay representations of breast cancer. Psychology & Health, 5, 1–11. doi:10.1080/08870449008400405.
Popay, J., Rogers, A., & Williams, G. (1998). Rationale and standards for the systematic review of qualitative literature in health services research. Qualitative Health Research, 8(3), 341–351. doi:10.1177/104973239800800305.
Pourtois, J. -P., & Desmet, H. (1989). Pour une recherche qualitative et néanmoins scientifique. Réseaux, 55-56-57, 13–35.
Provencher, D., Lalonde, L., Maugard, C., Foulkes, W., Aldis, A., Beaulieu, M.-D., et al. (2004). Multimodality breast cancer screening program for high-risk women (presence of high probability of BRCA mutation). Research protocol submitted to the Quebec Breast Cancer Foundation.
Rees, G., Fry, A., & Cull, A. (2001). A family history of breast cancer: women’s experiences from a theoretical perspective. Social Science & Medicine, 52, 1433–1440. doi:10.1016/S0277-9536(00)00248-3.
Richards, M. P. M., Hallowell, N., Green, J. M., Murton, F., & Statham, H. (1995). Counselling families with hereditary breast and ovarian cancer: a psychosocial perspective. Journal of Genetic Counseling, 4(3), 219–233. doi:10.1007/BF01408411.
Sauven, P., Bailsam, A., Eeles, R., Evans, G., Gilbert, F., Gui, G., et al. (2004). Guidelines for the management of women at increased familial risk of breast cancer. European Journal of Cancer, 40(5), 653–665. doi:10.1016/j.ejca.2003.10.028.
Schwartz, M. D., Hughes, C., Roth, J., Main, D., Peshkin, B. N., Isaacs, C., et al. (2000). Spiritual faith and genetic testing decisions among high-risk breast cancer probands. Cancer Epidemiology, Biomarkers & Prevention, 9, 381–385.
Senior, V., Marteau, T. M., & Weinman, J. (2000). Impact of genetic testing on causal models of heart disease and arthritis: an analogue study. Psychology & Health, 14, 1077–1088. doi:10.1080/08870440008407368.
Spratt, J. S., & Spratt, J. W. (1992). Legal perspectives on mammography and self-referral. Cancer, 69, 599–600. doi:10.1002/1097-0142(19920115)69:2<599::AID-CNCR2820690252>3.0.CO;2-R.
Vernon, S. W., Vogel, V. G., Halabi, S., & Bondy, M. L. (1993). Factors associated with perceived risk of breast cancer among women attending a screening program. Breast Cancer Research and Treatment, 28(2), 137–144. doi:10.1007/BF00666426.
Wainberg, S., & Husted, J. (2004). Utilization of screening and preventive surgery among unaffected carriers of a BRCA1 or BRCA2 gene mutation. Cancer Epidemiology, Biomarkers & Prevention, 13(12), 1989–1995.
Wardle, F. J., Collins, W., Pernet, A. L., Whitehead, M. I., Bourne, T. H., & Campbell, S. (1993). Psychological impact of screening for familial ovarian cancer. Journal of the National Cancer Institute, 85, 653–657. doi:10.1093/jnci/85.8.653.
Warner, E. (2004). Intensive radiologic surveillance: a focus on the psychological issues. Annals of Oncology, 15(Supplement 1), i43–i47. doi:10.1093/annonc/mdh657.
Wellisch, D. K., Gritz, E. R., Schain, W., Wang, H. J., & Siau, J. (1992). Psychological functioning of daughters of breast cancer patients. Part II: Characterizing the distressed daughter of the breast cancer patient. Psychosomatics, 33, 171–179.
Wellisch, D. K., Schain, W., Gritz, E. R., & Wang, H. J. (1996). Psychological functioning of daughters of breast cancer patients. Part III: Experiences and perceptions of daughters related to mother’s breast cancer. Psycho-Oncology, 5, 271–281. doi:10.1002/(SICI)1099-1611(199609)5:3<271::AID-PON227>3.0.CO;2-Z.
Wroe, A. L., Salkovskis, P. M., & Rimes, K. A. (1998). The prospect of predictive testing for personal risk: attitudes and decision making. Behaviour Research and Therapy, 36(6), 599–619. doi:10.1016/S0005-7967(98)00029-1.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Proulx, M., Beaulieu, MD., Loignon, C. et al. Experiences and Decisions that Motivate Women at Increased Risk of Breast Cancer to Participate in an Experimental Screening Program. J Genet Counsel 18, 160–172 (2009). https://doi.org/10.1007/s10897-008-9202-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10897-008-9202-z